The approval is for the 1.2ml and 2.4ml prefilled pen injections that reference AstraZeneca’s Byetta. "Amneal files again for ...
The new authorisation has been granted for a single-dose, pre-filled pen device that requires no ... and AZ'[s twice-daily exenatide formulation, Byetta. After 28 weeks of treatment, patients ...
Amneal Pharmaceuticals (NASDAQ:AMRX) has received FDA approval for its generic version of the GLP-1 agonist diabetes drug Byetta and resubmitted its New Drug Application for a prefilled syringe ...